G. K. Goh Holdings has evolved from its origins as a leading Singapore-based regional securities business (1979-2005) into an investment company owning operating businesses as well as a diverse portfolio of investments. The latter includes directly-held listed equities, unlisted equities, third-party managed funds, as well as a small number of non-controlling minority stakes.
We are trusted partners for our co-investors, such as private equity firms, family offices and insurance companies, and we seek opportunities wherever the potential returns are sufficiently attractive after adjusting for risks.
The group’s investments in recent years have included aged care in Australia, optic fibre networks in Europe, early-stage science-based start-ups in the United Kingdom, and real estate and tourism assets in Japan.
Mr Goh Geok Khim has been Executive Chairman of the Company since his appointment as Director on 28 March 1990. He is a member of the Nominating Committee, and was last re-elected on 21 April 2022.Mr Goh started his career in his family’s business, which was active in trading, rubber, property and manufacturing steel products. He left in 1968 to join the stockbroking industry, starting the G. K. Goh stockbroking group in 1979.Mr Goh is Chairman of the Boards of Temasek Foundation International CLG Limited and Federal Iron Works Sdn Bhd. He is also a director of Temasek Foundation Ltd and TF IPC Ltd.Mr Goh holds a Bachelor of Science degree in Civil Engineering from the University of Colorado.
Mr Goh Yew Lin has been an Executive Director of the Company since 28 March 1990, and was appointed as the Managing Director on 1 March 2008. He joined the G. K. Goh Group in 1984. He was last re-elected on 22 June 2020.Mr Goh is the Chairman of Seviora Holdings Pte Ltd, Xora Innovation Pte Ltd, Singapore Symphonia Company Ltd, and Duke-NUS Medical School.Mr Goh holds a Bachelor of Science (Economics) degree from the University of Pennsylvania’s Wharton School.
Executive Director and Chief Financial Officer
Mr Thomas Teo joined the Company as its Chief Financial Officer on 12 April 2006 and was appointed the Executive Director on 13 August 2018. His executive responsibilities include financial and investment management as well as board representation on various subsidiaries and associates of the Group. He was last re-elected on 21 April 2022.Prior to joining the Group, Mr Teo was with a regional private equity group for ten years, responsible for direct investments in the Asean region. He also spent eight years with Ernst and Young, Singapore and has had extensive experience in audit and corporate finance.Mr Teo is an independent director of an Australian listed company, OM Holdings Limited, serving as its Audit Committee Chairman.Mr Teo holds a Master of Business in Information Technology from the Royal Melbourne Institute of Technology and a Bachelor of Accountancy from the National University of Singapore. He is also a Fellow of the Institute of Singapore Chartered Accountants.
Mr David Lim was appointed as an independent director of the Company on 23 April 2013. He is currently Chairman of the Remuneration and Nominating Committees and a member of the Audit Committee. He was last re-elected on 22 June 2020.Mr Lim is the founder and Managing Partner of David Lim & Partners LLP with over thirty years of experience in corporate finance and litigation. He has represented multiple corporations from a myriad of sectors including finance and banking, fund management, private equity, oil and gas, healthcare, construction, information technology and communications, among others. He was a member of the Corporate Governance Council 2017/2018 and is a Fellow of the Singapore Institute of Directors.Mr Lim is the Non-Executive Chairman of Allium Healthcare (Singapore) Pte Ltd, a subsidiary of the Company.Mr Lim is also currently Chairman and Independent Non-Executive Director of Elite Commercial REIT Management Pte Ltd, Manager of Elite Commercial REIT.Mr Lim qualified as a barrister-at-law at Gray’s Inn, London. He is admitted as an Advocate & Solicitor of the Supreme Court of Singapore.
Mr Nagaraj Sivaram was appointed as an independent director of the Company on 1 July 2021. He is the Chairman of the Audit Committee and a member of the Remuneration and Nominating Committees. He was last re-elected on 21 April 2022.Mr Sivaram has forty years of external audit experience and is currently a board member and Audit Committee Chairman of the Land Transport Authority, Singapore Institute of Technology and Singapore Turf Club.Mr Sivaram has a Bachelor of Commerce degree from the University of Bombay, and is a fellow of the Institute of Chartered Accountants in England & Wales and the Institute of Singapore Chartered Accountants.
Ms Marie Elaine Teo was appointed as an independent director of the Company on 1 September 2017. She is currently a member of the Remuneration, Nominating and Audit Committees. She was last re-elected on 26 April 2021.Ms Teo has over twenty years of investment experience, primarily with the Capital Group companies where she focused on Asian banks and global emerging markets, both as an analyst and an investment manager. She was formerly the Chairman of Capital International Research Group and Managing Director of Capital International Inc., Asia. Ms Teo was also previously a senior advisor and partner of the Holdingham Group.She is currently a non-executive independent director of Olam International Limited and Monde Nissin Corporation, and a director of Mapletree Investments Pte Ltd, Mapletree Oakwood Pte Ltd and ICHX Tech Pte Ltd. She also serves as the Chairman of The Teng Ensemble.A former student of CHIJ St Nicholas Girls’ School, Ms Teo holds a Bachelor of Art (Honours) in Experimental Psychology from St Edmund Hall, Oxford University and a Masters in Business Administration from INSEAD, Fontainebleau.
Chief Executive Officer, Allium Healthcare Holdings Pte Ltd
Mr Bernie Poh joined the Group as the Senior Vice President for Aged Care in January 2013 and was appointed the Executive Director and Chief Executive Officer of Allium Healthcare Holdings Pte Ltd in April 2017. He also represents the Group as a Director on the Board of Opal HealthCare Group.Mr Poh has over twenty years of extensive experience in both the private and public healthcare sectors. Prior to joining the Group, he had served in various senior executive roles, which included Chief Executive Officer of Mount Elizabeth Hospital in Parkway Holdings Ltd (now IHH Healthcare Berhad) and Deputy Chief Executive Officer of the formerly SGX-listed Pacific Healthcare Holdings Ltd. During his employment in the public sector, he was a director at Health Sciences Authority.Mr Poh graduated from National University of Singapore with a bachelor’s degree in Business Administration. He also holds a Master of Business Administration from the Frankfurt School of Finance and Management and a Master of Social Work from the University of Hong Kong.